Xiao-Guo Suo
Impact in
-
- Chronic Kidney Disease and Diabetes
-
- Pharmacological Effects of Natural Compounds
Papers in
-
- Circular RNAs in diseases 2
-
- Chronic Kidney Disease and Diabetes 3
- Acute Kidney Injury Research 2
- Renal Diseases and Glomerulopathies 2
- Co-authors
- Xiao‐Ming Meng (12 shared papers)Yunyan Du (2 shared papers)Yang Wang (1 shared paper)Shengli Li (1 shared paper)Qi Sun (1 shared paper)Hongxing Li (1 shared paper)Wei‐Jian Ni (6 shared papers)Anqi Li (1 shared paper)
- Journals
- International Immunopharmacology (3 papers)European Journal of Pharmacology (2 papers)Journal of Ethnopharmacology (1 paper)Acta Pharmaceutica Sinica B (1 paper)Science Immunology (1 paper)
- Partner nations
- ChinaSaint Kitts and Nevis
In The Last Decade
Xiao-Guo Suo
15 papers receiving 175 citations
Peers
Comparison fields: 5 of 65
- Nephrology 24
- Pharmacology 14
- Molecular Biology 110
- Cancer Research 19
- Pathology and Forensic Medicine 18
Countries citing papers authored by Xiao-Guo Suo
This map shows the geographic impact of Xiao-Guo Suo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao-Guo Suo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao-Guo Suo more than expected).
Fields of papers citing papers by Xiao-Guo Suo
This network shows the impact of papers produced by Xiao-Guo Suo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao-Guo Suo. The network helps show where Xiao-Guo Suo may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiao-Guo Suo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 41 | |
| 2 | 2022 | 24 | |
| 3 | 2023 | 21 | |
| 4 | 2021 | 19 | |
| 5 | 2019 | 14 | |
| 6 | 2022 | 13 | |
| 7 | 2023 | 13 | |
| 8 | 2022 | 8 | |
| 9 | 2022 | 8 | |
| 10 | 2024 | 4 | |
| 11 | 2022 | 3 | |
| 12 | 2022 | 3 | |
| 13 | 2024 | 2 | |
| 14 | 2024 | 1 | |
| 15 | 2025 | 1 |
About Xiao-Guo Suo
Xiao-Guo Suo is a scholar working on Molecular Biology, Nephrology, Cancer Research, Pulmonary and Respiratory Medicine and Immunology, having authored 15 papers that have together received 175 indexed citations. Recurring topics across this work include Chronic Kidney Disease and Diabetes (3 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers), MicroRNA in disease regulation (2 papers), Acute Kidney Injury Research (2 papers), Kidney Stones and Urolithiasis Treatments (2 papers), Circular RNAs in diseases (2 papers), Renal cell carcinoma treatment (2 papers) and Renal Diseases and Glomerulopathies (2 papers). The work is most often cited by research in Nephrology (24 citations), Pharmacology (14 citations), Molecular Biology (110 citations), Cancer Research (19 citations) and Pathology and Forensic Medicine (18 citations). Xiao-Guo Suo has collaborated with scholars based in China and Saint Kitts and Nevis. Frequent co-authors include Xiao‐Ming Meng, Yunyan Du, Yang Wang, Shengli Li, Qi Sun, Hongxing Li, Wei‐Jian Ni, Anqi Li, Jiahao Zhang and Mingming Liu. Their work appears in journals such as International Immunopharmacology, European Journal of Pharmacology, Journal of Ethnopharmacology, Acta Pharmaceutica Sinica B and Science Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.